| Serum Levels of Autoantibodies and the Risk of Non-Hodgkin Lymphoma and Multiple Myeloma |
Jonathan Hofmann |
DCEG - Other |
PLCO |
Mar 9, 2015 |
2015-0051 |
| Pooled analysis of prospective cohort studies: the association between sex steroid hormones and esophageal/gastric cardia adenocarcinoma incidence |
Jessica Petrick |
NCI, DCEG, HREB |
PLCO |
Mar 9, 2015 |
2015-0040 |
| Development and validation of an oral cancer risk prediction model |
Anil Chaturvedi |
National Cancer institute |
PLCO |
Mar 9, 2015 |
PLCO-133 |
| Dietary predictors of colorectal adenoma in different racial subgroups using three different methods of dietary evaluation |
Alyson Haslam |
University of Georgia |
PLCO |
Feb 25, 2015 |
PLCO-131 |
| Comparing NLST/PLCO versus Yunnan Tin Miners study with chest X-ray screening |
Ping Hu |
NCI |
PLCO |
Feb 4, 2015 |
PLCO-128 |
| Components of survival time of screen detected cancer cases |
Philip Prorok |
NCI |
PLCO |
Feb 3, 2015 |
PLCO-129 |
| Assessing the value of a SNP-based score to predict outcomes from prostate cancer screening |
Hormuzd Katki |
NCI |
PLCO |
Feb 3, 2015 |
PLCO-127 |
| Ovarian Cancer Health Disparities in the Aging Population of the United States |
Adrian Badana |
Georgia Southern University |
PLCO |
Jan 15, 2015 |
PLCO-126 |
| Disparities in Prostate Cancer Screening Behavior Between Blacks and Whites |
Wayne Lawrence |
Jiann-Ping Hsu College of Public Health |
PLCO |
Jan 9, 2015 |
PLCO-125 |
| Genome-wide association analysis of genetic variants and prostate cancer risk and prognosis |
Qingyi Wei |
Duke Cancer Institute |
PLCO |
Dec 22, 2014 |
PLCO-124 |
| Retrieval of HPV-driven tumors for HPV analysis |
Aimee Kreimer |
NIH |
PLCO |
Dec 16, 2014 |
PLCO-123 |
| The Influence of Self-Reported Finasteride Use on the Incidence of Renal Cancer |
Michael Liss |
University of Texas Health Science Center San Antonio |
PLCO |
Dec 16, 2014 |
PLCO-120 |
| Lung Cancer Risk by Time Since Quit Smoking |
Paul Pinsky |
NCI |
PLCO |
Dec 15, 2014 |
PLCO-122 |
| Medication use in older people: a study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening cohort (PLCO) |
Amanda Black |
NCI/DCEG |
PLCO |
Dec 11, 2014 |
PLCO-121 |
| Metabolomic profiling for pancreatic cancer risk in the PLCO Cancer Screening Trial |
Amrita Cheema |
Georgetown University |
PLCO |
Nov 25, 2014 |
PLCO-119 |
| Influence of circulating testosterone concentrations on the relationship between 25(OH)D and prostate cancer |
Stephanie Weinstein |
NCI |
PLCO |
Nov 19, 2014 |
PLCO-113 |
| Validation of breast cancer risk models in PLCO |
Montserrat Garcia-Closas |
NCI/DCEG |
PLCO |
Nov 14, 2014 |
PLCO-116 |
| Causal Inference for Prostate Cancer Screening and Treatment using a Bayesian Hierarchical Latent Class Approach |
Rebecca Y Coley |
Johns Hopkins Bloomberg School of Public Health |
PLCO |
Nov 12, 2014 |
PLCO-118 |
| Cause of death in the NLST and PLCO: comparison of death certificates and endpoint adjudication |
Pamela Marcus |
NCI |
PLCO |
Nov 10, 2014 |
PLCO-117 |
| Type 1 and Type 2 ovarian cancer in the PLCO Trial |
Keith Terada |
University of Hawaii |
PLCO |
Nov 4, 2014 |
PLCO-115 |
